Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37
United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ted Yednock
15 Oct 2024
EVP & Chief Innovation Officer
Sold after exercise
5,408
$7.41
$40.07K
Ted Yednock
27 Dec 2023
EVP & Chief Innovation Officer
Sold after exercise
21,000
$4.52
$94.97K
Douglas Love
16 Sep 2021
President & CEO
Sold after exercise
7,500
$22.05
$165.34K
Jennifer Lew
13 Sep 2021
EVP & Chief Financial Officer
Sold after exercise
3,500
$20.01
$70.03K
Ted Yednock
13 Sep 2021
EVP & Chief Scientific Officer
Sold after exercise
16,190
$20.00
$323.86K
Douglas Love
8 Jun 2021
President & CEO
Sold after exercise
3,750
$22.55
$84.56K
Douglas Love
7 Jun 2021
President & CEO
Sold after exercise
3,750
$22.31
$83.67K
Ted Yednock
3 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
2,184
$21.72
$47.44K
Ted Yednock
3 Jun 2021
EVP & Chief Scientific Officer
Sold after exercise
12,816
$21.45
$274.88K
Jennifer Lew
27 May 2021
EVP & Chief Financial Officer
Sold after exercise
3,500
$22.24
$77.84K
Douglas Love
1 Apr 2021
President & CEO
Sold after exercise
300
$28.01
$8.40K
Douglas Love
1 Apr 2021
President & CEO
Sold after exercise
200
$28.19
$5.64K
Douglas Love
31 Mar 2021
President & CEO
Sold after exercise
7,102
$28.11
$199.62K
Douglas Love
30 Mar 2021
President & CEO
Sold after exercise
1,850
$24.78
$45.85K
Douglas Love
30 Mar 2021
President & CEO
Sold after exercise
1,900
$24.27
$46.12K
Douglas Love
29 Mar 2021
President & CEO
Sold after exercise
300
$27.24
$8.17K
Douglas Love
29 Mar 2021
President & CEO
Sold after exercise
600
$26.42
$15.85K
Douglas Love
29 Mar 2021
President & CEO
Sold after exercise
2,850
$25.02
$71.31K
Ted Yednock
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
237
$29.96
$7.10K
Ted Yednock
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
5,680
$29.21
$165.91K
Ted Yednock
25 Mar 2021
EVP & Chief Scientific Officer
Sold after exercise
10,258
$28.54
$292.76K
Sanjay Chandru Keswani
24 Mar 2021
EVP & Chief Medical Officer
Sold after exercise
3,995
$30.17
$120.51K
Jennifer Lew
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,800
$29.16
$52.49K
Jennifer Lew
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,800
$28.43
$51.17K
Jennifer Lew
23 Mar 2021
EVP & Chief Financial Officer
Sold after exercise
1,400
$27.51
$38.51K

What was left out

Form 4 filings counted 172
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 25
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 10,927,333
Sales filed before the plan box existed 5
History held since 24 Jul 2020